What Happened?
A number of stocks jumped in the afternoon session after the software sector caught a massive tailwind, fueled by easing geopolitical tensions and a fresh wave of AI-driven M&A.
Over the weekend, President Trump abruptly called off a planned military offensive against Iran. Yielding to pressure from Gulf allies, the administration shifted toward diplomatic talks to reopen the Strait of Hormuz. This critical de-escalation relieved pressure on global energy markets and inflation expectations, accelerating a drop in Treasury yields.
For software, this shifting macro backdrop is the perfect catalyst. Lower interest rates reduce the discount rate applied to expected future cash flows, driving capital back into growth-oriented tech equities. Furthermore, a lower-yield environment provides cheaper borrowing costs to fund ongoing AI development and the aggressive acquisitions currently sweeping the industry.
Strategic dealmaking continues to accelerate. Yellow.ai, a global leader in enterprise agentic AI, announced a $550 million SPAC merger with Bluerock Acquisition Corp to go public under the ticker "YAI." Meanwhile, financial automation leader AutoRek acquired Grath to integrate its AI-driven reconciliation and compliance technology.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Banking Software company nCino NASDAQ:NCNO jumped 3.7%. Is now the time to buy nCino?
- Marketing Software company Braze NASDAQ:BRZE jumped 3.5%. Is now the time to buy Braze?
- Automation Software company ServiceNow NYSE:NOW jumped 3.7%. Is now the time to buy ServiceNow?
- Data Analytics company Health Catalyst NASDAQ:HCAT jumped 6.4%. Is now the time to buy Health Catalyst? Access our full analysis report here, it’s free.
- Network Security company Palo Alto Networks NASDAQ:PANW jumped 2.6%. Is now the time to buy Palo Alto Networks? Access our full analysis report here, it’s free.
Zooming In On Health Catalyst (HCAT)
Health Catalyst’s shares are extremely volatile and have had 55 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 17 days ago when the stock dropped 2.2% on the news that sentiment continued to weaken as tech stocks faced a dual headwind of deteriorating macro conditions and an unwinding of retail leverage. The fundamental pressure stems from a sudden oil shock. A reinstated U.S. naval blockade on Iran pushed Brent crude past $85 a barrel, raising expectations that the Federal Reserve will hold rates in the 3.50%–3.75% range. For the software sector, this higher cost of capital could drive stricter scrutiny of AI investments. Investors might be hesitant to fund massive, margin-dilutive infrastructure buildouts without a clear timeline for returns.
Health Catalyst is down 2.4% since the beginning of the year, and at $2.23 per share, it is trading 41.8% below its 52-week high of $3.82 from August 2025. Investors who bought $1,000 worth of Health Catalyst’s shares 5 years ago would now be looking at only $38.76.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.